Here's a new research article that offers some evidence to support Stephanie Seneff's claim that Alzheimer's disease is a result of insufficient fatty acids/cholesterol in the brain. This is based on animal studies, because apparently no one has ever done similar studies on humans, but it should be valid for humans as well.
This doesn't really prove anything, of course, but it suggests that it probably behooves us to maintain a decent level of omega-3 fatty acids in our body, at all times, as insurance against Alzheimer's disease.
http://iospress.metapress.com/content/lvn663216uj58634/Therefore, we performed a systematic review (SR) and meta-analysis of the literature that focused on effects of the relatively long-term omega-3 FA supplementation (minimum period; 10% of average total lifespan) on cognitive impairment, amyloid-β pathology, and neuronal loss in animal models of AD. This SR shows that long-term omega-3 FA supplementation decreased the omega-6/omega-3 FA ratio and reduced the amount of amyloid-β in experimental animal models of AD. Omega-3 FA supplementation also improved cognitive function; this effect appeared larger in rats compared to mice, and in males compared to females. Moreover, omega-3 FA supplementation diminished the amount of neuronal loss, especially in female animals. The results of this SR indicate that it might be worthwhile to perform new clinical trials with long-term omega-3 FA supplementation in AD patients.
Tex

Visit the Microscopic Colitis Foundation Website




